1,500+
Veeva life sciences customers globally
Source: Veeva FY2026 corporate disclosure
TL;DR
Key Takeaways
- Veeva Systems is the dominant life sciences vertical SaaS with approximately 1,500+ customers; all top 20 pharma are Veeva customers.
- Publicly held (NYSE: VEEV). Founded 2007 by Peter Gassner. HQ: Pleasanton, CA.
- BizzContacts maintains 1,250+ verified Veeva records with 99% accuracy and 97.6% inbox deliverability.
- Mid-cap pharma and specialty pharma (1,000-19,999 employees) form ~48% of the install base.
- The Director of Veeva Operations / Veeva CoE Lead is uniquely Veeva-aware.
- United States accounts for ~43% of customers; Europe ~32%; Japan ~7%.
- Veeva Vault CRM migration deadline 2030, peak migration evaluation window 2026-2028.
- Veeva Data Cloud launches 2024 for AI-augmented commercial intelligence.
By the numbers
Veeva Install Base by the Numbers
Quotable statistics on the Veeva install base, sourced from Veeva 10-K filings, investor disclosures, and BizzContacts proprietary verification.
20 of 20
Top 20 global pharma are Veeva customers
Source: Veeva corporate disclosure
2030
Veeva Vault CRM migration deadline (off Salesforce)
Source: Veeva 2022 strategic announcement
1,250+
Verified BizzContacts Veeva records
Source: BizzContacts Q1 2026 audit
~43%
Share of Veeva customers in the United States
Source: BizzContacts geographic analysis
97.6%
Inbox deliverability on BizzContacts Veeva list
Source: Third-party audit, Q1 2026
Under 2.3%
Bounce rate, 30-day replacement guarantee
Source: BizzContacts SLA, 2026
5.9x
Reply rate vs generic life sciences IT list
Source: BizzContacts customer benchmark, 2026
What is it
What Is the Veeva Customers List?
The Veeva customers list is a verified, regularly refreshed database of life sciences organisations running Veeva in production, with named decision-makers on every record. Each entry carries the specific Veeva products live (Development Cloud: eTMF, CTMS, EDC, Study Startup, QualityDocs, QMS, Safety, RIM; Commercial Cloud: CRM, Engage, MyInsights, Suggestions, PromoMats, MedComms, Network, Compass, Crossix, Link, OpenData; Data Cloud), the life sciences sub-segment, Vault CRM migration status, company firmographics, therapeutic area focus where derivable, and the Veeva SI partner where publicly disclosed.
Buyers use it for outbound into the Veeva ecosystem: Vault CRM migration services, AI for HCP engagement, medical affairs and MSL platforms, real-world evidence and patient data, modern eTMF and EDC alternatives, quality and regulatory platforms, and data activation on Veeva commercial data. Records ship with firmographics, named decision-makers, and audit-trail metadata.
Sample contacts
Sample Veeva Systems Decision-Maker Contacts
A scrolling preview of the kinds of decision-makers on the Veeva Systems customers list, the commercial, clinical, quality, and regulatory leaders at life sciences organisations running Veeva Systems.
Illustrative preview records with masked emails, not real individuals. Every delivered Veeva Systems record is corporate-directory verified and ships unmasked.
02Top customers
What Companies are Using Veeva Systems?
List of Companies That Use Veeva Systems:
03Definition
Why a Veeva Customer List Matters in 2026
Veeva's transition from the Salesforce-based CRM to Veeva Vault CRM, announced in 2022 and mandatory by 2030, is the largest forcing function in life sciences software right now. Every Veeva CRM customer, which in practice means every major pharma, has to either migrate to Vault CRM or evaluate alternatives, and 2026 to 2028 is the peak evaluation period. Veeva Data Cloud, next-best-action in CRM Suggestions, and Veeva's R&D AI work all land over the same stretch.
Veeva's bundled coverage across Development Cloud and Commercial Cloud is deep for life sciences-specific workflows. Specialist vendors still win on depth in AI-led HCP engagement, medical affairs, real-world evidence, patient services, modern eTMF and CTMS, Snowflake-anchored data activation, and Vault CRM migration services.
BizzContacts isolates the Veeva install base as a separately filterable cohort so those vendors can run focused outbound into pharma Chief Commercial Officers, VP Commercial Operations, Directors of Veeva Operations, CIOs Life Sciences, and VP Clinical, Quality, and Regulatory leadership during the 2026 to 2028 migration window.
04Adoption
Life Sciences Companies Running Veeva
Veeva concentrates in life sciences companies (100-200,000+ employees) across large pharmaceutical companies (all top 20 global pharma run Veeva), mid-cap pharma and biotech, emerging biotech (venture-backed, pre-commercial through commercial-stage), medical device companies, animal health, consumer health (Rx and OTC), contract research organisations (CROs), contract development and manufacturing organisations (CDMO/CMO), generics and biosimilars manufacturers, specialty pharma, gene therapy and cell therapy companies, rare disease pharma, and other life sciences industries. The platform's life sciences vertical depth (purpose-built for pharma workflows like sample/expense management, MSL operations, HCP/HCO master data, clinical trial master file, regulatory submissions to FDA/EMA/PMDA, GxP-compliant quality management) and the rapidly expanding Veeva Data Cloud commercial intelligence make it the default life sciences SaaS platform globally.
Customer skew is mid-cap and large pharma (1,000-50,000 employees, approximately 52%) with strong presence at emerging biotech (100-999 employees, approximately 28% reflecting Veeva's strong venture-backed biotech adoption) and meaningful presence at global pharma (50,000-200,000+ employees, approximately 20% reflecting all top 20 pharma penetration). Veeva's customer count is concentrated relative to other vertical SaaS platforms (1,500+ customers) but the dollar value per customer is exceptionally high reflecting Veeva's deep ARR per pharma customer (often $5M-$50M+ ARR per top-20 pharma customer).
05Adoption
Veeva Adoption by Life Sciences Sub-Segment
Veeva concentrates exclusively in life sciences industries with verticalized depth across pharma, biotech, medical device, and supporting ecosystem.
A visual read of the adoption table above — longer bars mark the industries with the highest share of companies running Veeva Systems.
Large Pharmaceutical (top 20 global)
100%
Mid-cap Pharma and Specialty Pharma
Very High
Emerging and Mid-cap Biotech
Very High
Medical Device Companies
Very High
Animal Health Pharma
High
Consumer Health (Rx + OTC)
High
Contract Research Organisations (CROs)
Very High
CDMO and CMO (manufacturing)
Very High
Generics and Biosimilars
High
Gene Therapy and Cell Therapy
Very High
Rare Disease Pharma
Very High
Vaccines Manufacturers
Very High
Diagnostic Companies (life sciences)
High
Digital Therapeutics
High
Veterinary Pharma
High
All 20 of the world's top 20 global pharmaceutical companies run Veeva, representing 100% penetration at the top tier. This is exceptional for any vertical SaaS platform.
Veeva CRM penetration is approximately 80% of the global pharma sales rep base, making Veeva CRM the de facto standard for pharma commercial operations.
Vault eTMF (electronic Trial Master File) is the dominant clinical trial document management system globally, used at all top 20 pharma and most mid-cap pharma and biotech for clinical trials.
Vault QualityDocs and Vault QMS are exceptionally strong at pharma manufacturing (GxP) and have expanded into medical device, food and beverage adjacent (QualityOne).
Veeva Network (HCP/HCO master data) is the dominant healthcare professional master data platform in life sciences commercial operations.
06Geo coverage
Veeva Adoption by Country
Veeva is a global life sciences SaaS with strong US, European, Japanese, and emerging market presence.
The United States accounts for approximately 43% of Veeva customer count, the largest single market.
Europe collectively (UK + Germany + Switzerland + France + Italy + Spain + Sweden + other EU) accounts for approximately 32% of customers reflecting Europe's strong pharmaceutical industry concentration.
Japan is exceptionally strong relative to size at ~7% of customers, driven by Takeda, Otsuka, Daiichi Sankyo, Astellas, and other Japanese pharma.
Asia-Pacific (Japan + China + India + South Korea + Australia) accounts for approximately 24% of customers reflecting Veeva's APAC growth investment.
Companies Using Veeva Systems by Country and Continent
A country-by-country read on where Veeva Systems adoption clusters, cross-checked against public technology-usage datasets and BizzContacts verification. Numbers are directional estimates against a global base of roughly 1,500 Veeva customers; the USA, UK, Germany, and Switzerland lead the list as our core outbound markets.
Veeva Systems Users by Country
Veeva Systems Users by Continent
Country figures cover companies with an identifiable Veeva Systems deployment and do not sum to the continent totals, which also fold in smaller markets not listed individually. Ask us for a country- or region-scoped Veeva Systems segment and we will build and verify it within 2 to 3 business days.
07US footprint
Veeva Customers by US State
Veeva US deployments concentrate in life sciences hub states.
New Jersey hosts the most concentrated US Veeva customer cluster anchored by Big Pharma HQs (Merck, BMS, J&J Innovative Medicine) along the Princeton/Rahway/New Brunswick corridor.
Massachusetts Cambridge hosts the densest US biotech Veeva cluster anchored by Moderna, Vertex, and the broader Cambridge biotech ecosystem.
South San Francisco and the Bay Area host the densest emerging biotech Veeva cluster with BioMarin, Gilead, and venture-backed biotech adoption.
Research Triangle Park North Carolina hosts strong biotech and CRO Veeva concentration.
08Segmentation
Veeva Customer Size Distribution
Veeva concentrates in mid-cap to large life sciences with exceptional Top 20 pharma penetration.
A visual read of the size-distribution table above — longer bars mark the company-size bands with the highest share of companies running Veeva Systems.
Emerging biotech (100-499 employees)
20%
Growing biotech (500-999)
12%
Mid-cap pharma and biotech (1,000-4,999)
26%
Specialty pharma (5,000-19,999)
22%
Big pharma (20,000-49,999)
12%
Mega pharma (50,000-199,999)
8%
Mid-cap pharma and specialty pharma customers (1,000-19,999 employees) form the densest Veeva cohort (~48%). All 20 of the world's top 20 pharma run Veeva (100% penetration at the global mega-pharma tier). Emerging biotech (100-999) is a strong growth segment as biotech companies advance from clinical to commercial stage.
09Buyer titles
Decision-Makers at Veeva Customer Accounts
Veeva buying decisions cluster around life sciences functional leadership (Chief Commercial Officer, VP Clinical Operations, VP Quality, Director of Regulatory Affairs) and Veeva platform leadership (Director of Veeva Operations).
The Director of Veeva Operations / Veeva CoE Lead is uniquely Veeva-aware (rare title at non-Veeva accounts). Chief Commercial Officer and VP Commercial Operations for Commercial Cloud strategic pitches. VP Clinical Operations and VP Quality for Development Cloud functional pitches. Director of Regulatory Affairs for Vault RIM pitches. Director of MSL Operations for MSL-specific pitches. CIO Life Sciences for platform-level pitches including Vault CRM migration.
10Tech stack
Technology Ecosystem Around Veeva Customers
Veeva customers run a predictable adjacent stack of life sciences platforms, modern data platforms, BI tools, and life sciences SI partners.
Compared
Veeva vs IQVIA vs Medidata vs MasterControl vs Salesforce Health Cloud
Veeva and the four largest competing life sciences SaaS platforms compared by buyer focus and BizzContacts coverage.
Veeva wins on life sciences vertical SaaS depth and 100% top-20 pharma penetration. IQVIA wins on broader data and services. Medidata wins on clinical platform depth. MasterControl wins on quality and regulatory. Salesforce Health Cloud wins on Salesforce ecosystem anchored CRM alternatives.
11Benefits
Why Outbound Teams Use the Veeva Customers List
Sell into pharma Chief Commercial Officers and Directors of Veeva Operations
Reach the actual decision-makers at life sciences Veeva accounts.
Pitch Veeva Vault CRM migration SI services
Accenture, Deloitte, IQVIA, Cognizant, Capgemini target Veeva CRM Salesforce-based customers for 2030 Vault CRM migration.
Position modern AI for HCP engagement
Aktana, Veeva CRM Suggestions alternatives target Veeva CRM customers.
Run modern medical affairs and MSL platforms
Target Director of MSL Operations and Director of Medical Affairs at Veeva accounts.
Pitch data activation on Veeva commercial data
Snowflake, Databricks data activation target Veeva commercial customers.
Event marketing for Veeva Summit (Boston, Madrid, Tokyo)
Drive event engagement around Veeva's annual customer Summits.
Who buys this list
Which Businesses Can Use the Veeva Customers List
Veeva sits at the centre of life sciences commercial operations, clinical trial management, regulatory affairs, quality management, and pharmacovigilance at essentially every major pharmaceutical, biotech, and medical device company globally. The buyers below are the most common purchasers of the BizzContacts Veeva customers list.
01
Veeva Vault CRM migration SI partners
Accenture, Deloitte, IQVIA Technologies, Cognizant, Capgemini, ZS Associates target Veeva CRM Salesforce-based legacy customers for 2030 Vault CRM migration services.
Use case: Vault CRM migration, change management, training, integration re-platforming.
02
Modern AI for HCP engagement
Aktana, ZS Discovery, Indegene target Veeva CRM customers needing AI-augmented HCP engagement beyond Veeva CRM Suggestions.
Use case: AI for HCP next-best-action, LLM-augmented sales rep workflows, modern omnichannel pharma engagement.
03
Modern medical affairs and MSL platforms
Within3, Aktana Medical, OneStudyTeam target Veeva customers for medical affairs and MSL operations beyond Veeva CRM MedComms.
Use case: Medical affairs digital platforms, MSL workflows, modern HCP scientific engagement.
04
Modern real-world evidence and patient data platforms
Komodo Health, Health Verity, Definitive Healthcare, Tempus AI target Veeva customers for patient data and real-world evidence beyond Veeva Crossix and Link RWD.
Use case: Patient data analytics, real-world evidence generation, modern healthcare data, AI-augmented commercial insights.
05
Modern clinical platforms
Medidata Rave, Castor EDC, Veeva Vault EDC alternatives target Veeva customers for clinical platform alternatives or augmentation.
Use case: Modern clinical data capture, decentralized trials, modern eTMF/CTMS, AI-augmented clinical operations.
06
Modern quality and regulatory platforms
MasterControl, Sparta Systems TrackWise Digital, Dassault Systemes ENOVIA target Veeva customers for quality and regulatory platform alternatives.
Use case: Modern QMS, regulatory submissions, quality management for life sciences manufacturing.
07
Modern data platforms for Veeva commercial data
Snowflake, Databricks, Tableau, Power BI target Veeva customers for data warehousing and analytics on Veeva data.
Use case: Veeva data activation, commercial analytics, AI-augmented BI on Veeva data.
08
Modern master data management for life sciences
Reltio Connected Customer, Informatica MDM target Veeva customers needing modern MDM beyond or alongside Veeva Network.
Use case: Modern MDM, HCP/HCO master data, life sciences master data governance.
If your product or service touches life sciences commercial operations, clinical trial management, regulatory affairs, quality management, medical affairs, real-world evidence, master data management, or Vault CRM migration at a Veeva-running organisation, the BizzContacts Veeva list is the most direct path to qualified Chief Commercial Officer, VP Commercial Operations, Director of Veeva Operations, and CIO Life Sciences decision-makers.
12Buyer use cases
Why Businesses Purchase the Veeva Email List
Life sciences vertical title precision
Chief Commercial Officer, VP Commercial Operations, Director of Veeva Operations, CIO Life Sciences at Veeva accounts.
Veeva product filtering
Filter by Development Cloud apps (eTMF, CTMS, EDC, QualityDocs, QMS, Safety, RIM) and Commercial Cloud apps (CRM, Engage, Network, Compass, Crossix, OpenData, Data Cloud).
Veeva Vault CRM migration status filtering
Filter for customers still on Salesforce-based legacy CRM vs piloting Vault CRM vs migrated.
Life sciences sub-segment filtering
Filter by large pharma, mid-cap pharma, biotech, medical device, animal health, consumer health, CRO, CDMO/CMO, gene therapy, rare disease, vaccines, diagnostic.
Geography filtering
Filter by US, UK, Germany, Switzerland, Japan, France, Canada, China, India, Italy, Spain, Sweden, Australia, South Korea, Brazil.
Higher reply rates than generic life sciences lists
BizzContacts Veeva records benchmark at 5.9x the reply rate of generic life sciences IT lists.
13Data dictionary
What Every Veeva Record Includes
Every record on the BizzContacts Veeva customers list ships with the following fields.
14Trust signals
Why BizzContacts for Veeva Intelligence
Life sciences vertical title precision
Data resolves to Chief Commercial Officer, VP Commercial Operations, Director of Veeva Operations, CIO Life Sciences at Veeva accounts.
Product-level Veeva tagging
Every record tagged with specific Veeva Development Cloud and Commercial Cloud apps.
Veeva Vault CRM migration status tagging
Critical migration status (Salesforce legacy vs Vault CRM) tagged for 2030 migration-window pitches.
Life sciences sub-segment depth
Pharma vs biotech vs medical device vs CDMO sub-segmentation.
Hand-verified life sciences records
Every contact researched by a named analyst familiar with pharma title structures.
97.6% inbox deliverability
Multi-step email verification on every record.
How we build the data
How the Veeva Customers List Data Is Sourced
The BizzContacts Veeva customers list is built from a multi-channel research pipeline focused on confirming Veeva product footprint, life sciences sub-segment, employee count, Vault CRM migration status, and Veeva SI partner relationships, plus tagging each record with verified Chief Commercial Officer, VP Commercial Operations, Director of Veeva Operations, CIO Life Sciences decision-makers.
A record is shipped only when at least two independent sources confirm the Veeva deployment and the decision-maker contact is verified by the research desk within the trailing 30 days.
Customer voice
What Outbound Teams Say About BizzContacts Veeva Data
Director of Veeva Operations is uniquely Veeva-aware. BizzContacts gave us 380 pharma Veeva accounts including all top 20 pharma. Our reply rate jumped from 1.4% to 11.8%.
Vault CRM migration status filter (Salesforce-based legacy vs Vault CRM) was the differentiator for our 2030 migration consulting pitch. 14 enterprise pilots in one quarter.
Biotech sub-segment filter (mid-cap commercial-stage) was perfect for our medical affairs platform. 9 mid-cap biotech pilots in 90 days.
15Quick answers
Veeva Buyer Intelligence: Quick Answers
Short, direct answer blocks optimised for AI search engines and featured snippets.
Q: How many companies use Veeva?
A: Veeva reports approximately 1,500+ life sciences customers globally including all 20 of the world's top 20 pharma. BizzContacts verifies 1,250+ records.
Q: What is Veeva Vault?
A: Veeva's content management platform foundation supporting Development Cloud apps (clinical, regulatory, quality, safety) and content-centric Commercial Cloud apps (PromoMats, MedComms). Vault is Veeva-owned and runs on Veeva's proprietary platform (not Salesforce).
Q: What is Veeva CRM?
A: Veeva's customer relationship management product for pharma sales representatives and Medical Science Liaisons. Veeva CRM was historically built on Salesforce as a major vertical Salesforce ISV. In 2022 Veeva announced the new Vault CRM (Veeva-owned, not Salesforce-based), and is migrating all CRM customers to Vault CRM by 2030.
Q: What is the Veeva Vault CRM migration?
A: Veeva's strategic transition from the Salesforce-based legacy Veeva CRM to the new Veeva-owned Vault CRM, mandatory by 2030 for all Veeva CRM customers. The 2026-2028 window is the peak migration evaluation period for pharma customers.
Q: What is Veeva Data Cloud?
A: Veeva's new commercial data and AI platform (launched 2024), providing unified commercial data including HCP/HCO master data, patient data, real-world evidence, and AI-powered commercial intelligence.
Q: What is Veeva Network?
A: Veeva's HCP/HCO master data management product providing curated, regularly updated master data for healthcare professionals (HCPs) and healthcare organisations (HCOs) used in pharma commercial operations.
Q: What is Veeva OpenData?
A: Veeva's reference dataset of HCP and HCO information used by Veeva Network and Veeva CRM for accurate master data.
Q: How does Veeva compare to IQVIA?
A: Veeva is purpose-built life sciences SaaS with deep workflow depth. IQVIA is a broader life sciences data and services company with OneKey HCP data and Salesforce Health Cloud CRM. Veeva wins on Vault platform depth; IQVIA wins on data and services breadth.
Q: How does Veeva compare to Salesforce Health Cloud for Life Sciences?
A: Veeva CRM was historically built on Salesforce. Veeva is migrating off Salesforce to Vault CRM by 2030. Salesforce Health Cloud for Life Sciences (with IQVIA OneKey) competes for pharma CRM customers, particularly as Veeva CRM customers evaluate Vault CRM migration vs Salesforce-anchored alternatives.
Q: Who owns Veeva?
A: Veeva Systems is publicly held (NYSE: VEEV). Founded 2007 by Peter Gassner (CEO) and Matt Wallach. Headquartered in Pleasanton, CA.
Q: What industries use Veeva most?
A: Life sciences exclusively: large pharmaceutical (100% top 20 penetration), mid-cap pharma and specialty pharma, emerging and mid-cap biotech, medical device companies, animal health pharma, consumer health (Rx + OTC), CROs, CDMO/CMO manufacturing, generics and biosimilars, gene therapy and cell therapy, rare disease pharma, vaccines manufacturers, diagnostic companies.
Q: Where is the largest Veeva install base?
A: United States accounts for ~43% of customers. UK, Germany, Switzerland, Japan, France, Canada, China, India have largest non-US concentrations.
Q: How accurate is the BizzContacts Veeva list?
A: 99% record-accuracy SLA, 97.6% inbox deliverability, 30-day replacement guarantee.
Q: Can I filter by Veeva product?
A: Yes, by Development Cloud apps (eTMF, CTMS, EDC, Study Startup, QualityDocs, QMS, Quality Training, Safety, RIM) and Commercial Cloud apps (CRM, Engage, Network, Compass, Crossix, OpenData, Data Cloud).
Q: Can I filter by Vault CRM migration status?
A: Yes, critical for 2026-2028 Vault CRM migration window pitches.
16Search insights
People Also Ask About Veeva Customers
17FAQ
Veeva Customers List FAQs
18Full technology index
Every Technology Users Database Inside BizzContacts
Browse every install-base and technographic database BizzContacts maintains. Every link below points to a live BizzContacts landing page with verified customer records, decision-maker contacts, and buyer-center intel for that platform, updated on a continuous verification cycle.
142 technology users databases covered. Every entry links to a verified install-base landing page with buyer contacts.